Shan Jiang
Chief Technology OfficerDr. Shan Jiang is Chief Technology Officer of Hansoh Pharmaceutical Group Company Limited from August 2024. Dr. Jiang joined the Hansoh Pharmaceutical Group Company Limited in August 2024. Dr. Jiang has over 25 years of rich experience in the fields of biopharmaceuticals and ADC development. Prior to joining Group, Dr. Jiang served as vice president of Pfizer from December 2023 to May 2024, responsible for the management of the Pharmaceutical Science Biotherapeutics department. From July 2008 to December 2023, she held positions ranging from director to vice president at Seagen and was fully responsible for the development of large molecule pipelines. Dr. Jiang previously held R&D management positions at Bayer and BMS. Dr. Jiang obtained a bachelor’s degree in basic medical sciences from Beijing Medical University (currently known as Peking University Health Science Center ) in July 1993 and a doctorate degree in industrial and physical pharmacy from Purdue University in May 1998.
Positions
- Company NameHansoh Pharmaceutical Group Company LimitedStock Code03692PositionChief Technology Officer
